---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-287318"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2021-09-30T23:59:59+00:00"
generated_at: "2026-06-29T00:23:07.333199+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics names Judith Reinsdorf and Paul Silva to board, effective Oct 1

## Summary
- Judith Reinsdorf appointed to board and Governance Committee; Paul Silva to Audit Committee.
- Each receives initial option to purchase 35,000 shares vesting over three years.
- Reinsdorf is former EVP & GC of Johnson Controls; Silva is former SVP & CAO of Vertex.
- Appointments effective Oct 1, 2021; both also receive pro-rata cash retainers.

## SEC filing metadata
- accession: 0001193125-21-287318
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2021-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/d225615d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-287318
- JSON: https://secwatch.observer/filing/0001193125-21-287318.json
- Plain text: https://secwatch.observer/filing/0001193125-21-287318.txt

## Key facts
- Executive change
  Judith A. Reinsdorf was appointed as Director at Nurix Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm
- Executive change
  Paul M. Silva was appointed as Director at Nurix Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.